helpline 01494 601 400


One of our researchers using the TMS machine

Our research philosophy

Epilepsy Society funded research falls under four integrated areas: genomics, neuroimaging, neuropsychology and neuropathology (Epilepsy Society's Brain and Tissue Bank).  We also carry out research in other psychological and health service areas and epidemiology (global health and outcomes).

We are part of a unique arrangement with UCL Queen Square Institute of Neurology and the UCLH National Hospital for Neurology and Neurosurgery. This ensures academic and clinical excellence, patient input and relevance of our medical research. 

The close integration of the clinical and research activities at Epilepsy Society's Chalfont Centre ensures that the research questions addressed are relevant to clinical care and that advances are put into clinical practices without delay.

The ultimate goals of our current research are to spearhead personalised treatment and to incorporate genomic diagnosis into the NHS for people with epilepsy.

A person being scanned by our Transcranial Magnetic Stimulation (TMS) scanner (pictured right).

Experience our research


Neuropsychology looks at how epilepsy and seizures affect the way a person thinks, learns and behaves. It is particularly useful for assessing people before and after surgery for epilepsy.

Coming soon


Epidemiology helps us to look at epilepsy in the community and find out who, when and where people have developed the condition.

Coming soon

Epilepsy research papers

We've compiled a summary of our latest research papers for you to read, written by our powerhouse multidisciplinary team who contribute to a wide ranging spectrum of epilepsy research. 

These papers give you a snapshot of our teams clinical and research knowledge, which is helping us to further our understanding of people with epilepsy.


Life changing research

At age 30, Aidan was no longer responding to emergency medication.  Four times he had to be put into an induced coma to stop his seizures. Then genetic tests revealed he had a mutation in the SCN1A gene which was causing Dravet syndrome, a severe form of epilepsy. By prescribing him different medication, we were able to help bring his seizures under control.

Be part of our research

Join our team

Epilepsy Society’s Chalfont Centre is unique in bringing together intellectual capital to form a powerhouse multidisciplinary team who contribute to a wide ranging spectrum of research. It is only by working together that we will be able to translate the findings of our research into clinical medicine. 

At the moment we can only recruit people for our research who are under the care of UCLH.
Find out how to be considered for future research projects.

Epilepsy Society does not conduct research using animals. Read our policy statement here.